Gii'Igoshimong: Sitting With Your First Family

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohns Hopkins Bloomberg School of Public Health

About this trial

The goal of this randomized wait-list control study is to understand the relationship between ceremony and substance use (SU), SU risk (e.g., SU severity, depressive symptoms) and protective factors (e.g., spirituality, community support). The main questions it aims to answer are:

* Will adults enrolled in Gii'igoshimong show improved SU outcomes compared to those in control groups? * Will self-relevant processing networks activated during stimulus engagement increase from pre- to post- engagement in ceremony and at 6-month follow-up?

Researchers will compare adults that complete Gii'igoshimong with those that do not complete Gii'igoshimong to see if health outcomes are different.

After completing baseline assessments, participants will be randomized to complete Gii'igoshimong now (intervention) or after the participants have completed the 1 month and 6-month post assessments (waitlist control). All participants (intervention and waitlist control) within a cohort will complete 1 month and 6 month post assessments at the same time.

Eligibility criteria

Qualifiers

Are 18 years of age or older,

Self-identify as Ojibwe/Anishinaabe/Chippewa,

Self-report using any kind of substances in the past 30 days,

Have no history of head injury with loss of consciousness,

Disqualifiers

Younger than18 years of age

Does not Self-identify as Ojibwe/Anishinaabe/Chippewa,

Does not self-report using any kind of substances in the past 30 days,

Has history of head injury with loss of consciousness,

Trial design

Treatments tested in this trial

  • Ceremony

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Johns Hopkins Bloomberg School of Public Health

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator